Maiden Holdings, Ltd. annual report, FY2017

Maiden Holdings, Ltd. — 2017 Form 10-K

Business context and reporting period. This annual report covers the fiscal year ended December 31, 2017, with comparisons to 2016 and 2015. Maiden is a Bermuda-based reinsurer serving regional and specialty insurers, primarily through Diversified Reinsurance and AmTrust Reinsurance. AmTrust was the source of 70.8% of 2017 gross premiums written. Most business is quota-share reinsurance; the company generally avoids stand-alone catastrophe reinsurance.

Financial performance and position

Metric20172016
Gross premiums written$2.816 billion$2.831 billion
Net premiums written$2.762 billion$2.655 billion
Net premiums earned$2.733 billion$2.568 billion
Total revenues$2.921 billion$2.732 billion
Net income (loss)($169.7 million)$48.1 million
Net income (loss) attributable to common shareholders($199.1 million)$15.2 million
Operating cash flow$458.5 million$470.1 million
Combined ratio111.3%103.2%
Net investment income$166.3 million$145.9 million
Loss and LAE reserves$3.547 billion$2.896 billion
Total assets / total liabilities$6.644 billion / $5.412 billion$6.252 billion / $4.891 billion

Profitability and margins. The 111.3% combined ratio indicates an underwriting loss; reported underwriting loss was $277.1 million, versus $53.2 million in 2016. The loss and LAE ratio rose to 78.8% from 70.6%; the expense ratio was 32.5%, little changed. Non-GAAP operating loss attributable to common shareholders was $184.9 million, or $2.16 per share, compared with operating earnings of $17.3 million, or $0.22 per share, in 2016. Net investment income rose 14.0%, and average book yield increased to 3.1% from 3.0%.

Liquidity and capital. Cash and investments totaled $5.340 billion, including restricted assets; restricted cash and investments were approximately $4.869 billion. Operating cash flow remained positive, while investing activities used $378.9 million and financing activities used $60.4 million. Year-end principal debt was $262.5 million ($254.5 million net of issuance costs); debt was 17.6% of total capital resources. Total capital resources fell 13.3% to $1.495 billion. Common book value per share declined to $9.25 from $12.12. The company declared $0.60 per common share in dividends and repurchased 3.67 million shares for $25.7 million under its authorization.

Material changes and unusual items

  • Adverse prior-year loss development was $321.5 million, compared with $165.3 million in 2016. AmTrust accounted for $239.9 million, Diversified Reinsurance for $71.4 million, and run-off business for $10.2 million. More than half of the development was associated with a $171.0 million reserve charge in the fourth quarter.
  • Management also raised initial loss-ratio assumptions for current-year business in both operating segments, citing market conditions and recent loss trends. Excluding prior-year development, the consolidated loss ratio was 67.0%, versus 64.2% in 2016.
  • AmTrust Reinsurance swung to a $207.1 million underwriting loss from $30.1 million of underwriting income. Its combined ratio rose to 110.8% from 98.4%; adverse development included workers’ compensation and general liability. Diversified Reinsurance recorded a $59.5 million underwriting loss, though its combined ratio improved to 107.1% from 109.4%.
  • Net premiums written grew 4.0% despite a 0.5% decline in gross premiums written, mainly because Maiden used less retrocessional capacity. The retention ratio increased to 98.1% from 93.8%.
  • Maiden issued $150 million of 6.7% Series D preference shares and redeemed $100 million of 8.0% 2012 Senior Notes. This lowered debt principal, but preference shares carry non-cumulative dividends and rank ahead of common equity for dividends.
  • Foreign exchange shifted to a $14.9 million loss from a $11.6 million gain. The 2017 U.S. tax law change contributed a $5.0 million write-down of U.S. deferred tax liabilities and a reported $3.6 million income tax benefit.

Outlook, risks and contingencies

Management said underwriting initiatives and 2017 reserving actions were expected to improve operating returns in 2018 and support progress toward its long-term target of more than 15% operating return on common equity over the next 12–24 months. The filing gives no specific 2018 earnings or combined-ratio guidance; the long-term target had not been achieved.

Key risks include continued reserve deterioration, reliance on AmTrust and related-party arrangements, workers’ compensation and casualty loss trends, competitive pricing, investment and interest-rate exposure, foreign-exchange movements, and regulatory constraints on collateral and subsidiary dividends. Approximately 90.8% of fixed maturities and cash equivalents were pledged or restricted at year-end. The company reported no foreign-exchange hedges in force. A.M. Best maintained an A (Excellent), stable rating for the principal operating subsidiaries; after S&P downgraded its ratings in November 2017, Maiden requested their withdrawal. The AmTrust quota-share agreement was renewed through June 30, 2019, subject to termination provisions. A former executive’s whistleblower-related employment claim remained pending, with hearings expected to conclude in 2018. The 10-K reports unqualified audit opinions on the financial statements and internal control over financial reporting.

Important facts for investors to verify

  1. Whether the $321.5 million of adverse development, especially the fourth-quarter reserve charge, is sufficient or further deterioration emerges in subsequent loss reporting.
  2. Whether AmTrust’s claims handling, business mix and underwriting performance stabilize, given its 70.8% share of gross premiums and the large workers’ compensation and general-liability exposures.
  3. How much liquidity is practically available after collateral and regulatory restrictions, and whether subsidiary dividend capacity can support holding-company obligations and shareholder distributions.
  4. Whether the A.M. Best rating remains stable, and how the absence of an S&P rating affects client retention, new business and future access to capital.
  5. Whether management’s expected 2018 underwriting improvement is realized; the filing provides an outlook, not quantified guidance.
  6. The status and potential financial effect of the pending Turin claim, tax-law changes, and related-party collateral, loan and service arrangements.